Epidemiological and clinical differences of coronavirus disease 2019 patients with distinct viral exposure history

Since severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spread from the early epicenter, Wuhan, to the rest of China, the virulence of SARS-CoV-2 might have evolved at different phases of the pandemic. We therefore compared the unique features among 62 coronavirus disease 2019 (COVID-19)...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Yinjie Gao, Xuemei Ma, Jingfeng Bi, Jindong Chu, Bo Liu, Chunsheng Chi, Jianguo Yan, Xiaoli Yu, Fangming Liu, Xiaohong Deng, Hongbing Zhang, Bo Jin
Formato: article
Lenguaje:EN
Publicado: Taylor & Francis Group 2020
Materias:
Acceso en línea:https://doaj.org/article/0dea6c10186f428eb2dce132e7933820
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:0dea6c10186f428eb2dce132e7933820
record_format dspace
spelling oai:doaj.org-article:0dea6c10186f428eb2dce132e79338202021-11-17T14:21:58ZEpidemiological and clinical differences of coronavirus disease 2019 patients with distinct viral exposure history2150-55942150-560810.1080/21505594.2020.1802870https://doaj.org/article/0dea6c10186f428eb2dce132e79338202020-12-01T00:00:00Zhttp://dx.doi.org/10.1080/21505594.2020.1802870https://doaj.org/toc/2150-5594https://doaj.org/toc/2150-5608Since severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spread from the early epicenter, Wuhan, to the rest of China, the virulence of SARS-CoV-2 might have evolved at different phases of the pandemic. We therefore compared the unique features among 62 coronavirus disease 2019 (COVID-19) inpatients who contracted SARS-CoV-2 in Wuhan (15 cases), exposed to the patients from Wuhan (26 cases), or acquired the disease without exposure to Wuhan patients (21 cases). Median incubation periods are 4.5 days (3–5) for Wuhan patients, 8 days (3–11) for those infected by Wuhan patients, and 12 days (7–13) for those without aforementioned experience. The disease onset dates are earliest for Wuhan patients and latest for those without exposure to Wuhan patients. Blood lymphocytes were lowest in Wuhan patients, lower in those affected by Wuhan patients, and modest reduced in remaining ones. Disease severity is worst for Wuhan patients, and modest for those without contact with Wuhan patients. Wuhan patients had longest (27 days, 18–28), those transmitted by Wuhan patients had intermediate (16 days, 8–23), and the rest of the patients had shortest (13 days, 8.5–22.5) hospital stay. Early viral exposure, older age, lymphocytopenia, and underlying conditions are risk factors which warrant aggressive intervention. Even though the virulence of SARS-CoV-2 appears decline over the course of serial transmissions, viral testing, contact tracing, social distancing, and face masking should be imposed on general public to contain viral dissemination from both symptomatic and asymptomatic patients with this highly contagious disease.Yinjie GaoXuemei MaJingfeng BiJindong ChuBo LiuChunsheng ChiJianguo YanXiaoli YuFangming LiuXiaohong DengHongbing ZhangBo JinTaylor & Francis Grouparticlecoronavirussars-cov-2covid-19incubation periodpandemicvirulenceInfectious and parasitic diseasesRC109-216ENVirulence, Vol 11, Iss 1, Pp 1015-1023 (2020)
institution DOAJ
collection DOAJ
language EN
topic coronavirus
sars-cov-2
covid-19
incubation period
pandemic
virulence
Infectious and parasitic diseases
RC109-216
spellingShingle coronavirus
sars-cov-2
covid-19
incubation period
pandemic
virulence
Infectious and parasitic diseases
RC109-216
Yinjie Gao
Xuemei Ma
Jingfeng Bi
Jindong Chu
Bo Liu
Chunsheng Chi
Jianguo Yan
Xiaoli Yu
Fangming Liu
Xiaohong Deng
Hongbing Zhang
Bo Jin
Epidemiological and clinical differences of coronavirus disease 2019 patients with distinct viral exposure history
description Since severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spread from the early epicenter, Wuhan, to the rest of China, the virulence of SARS-CoV-2 might have evolved at different phases of the pandemic. We therefore compared the unique features among 62 coronavirus disease 2019 (COVID-19) inpatients who contracted SARS-CoV-2 in Wuhan (15 cases), exposed to the patients from Wuhan (26 cases), or acquired the disease without exposure to Wuhan patients (21 cases). Median incubation periods are 4.5 days (3–5) for Wuhan patients, 8 days (3–11) for those infected by Wuhan patients, and 12 days (7–13) for those without aforementioned experience. The disease onset dates are earliest for Wuhan patients and latest for those without exposure to Wuhan patients. Blood lymphocytes were lowest in Wuhan patients, lower in those affected by Wuhan patients, and modest reduced in remaining ones. Disease severity is worst for Wuhan patients, and modest for those without contact with Wuhan patients. Wuhan patients had longest (27 days, 18–28), those transmitted by Wuhan patients had intermediate (16 days, 8–23), and the rest of the patients had shortest (13 days, 8.5–22.5) hospital stay. Early viral exposure, older age, lymphocytopenia, and underlying conditions are risk factors which warrant aggressive intervention. Even though the virulence of SARS-CoV-2 appears decline over the course of serial transmissions, viral testing, contact tracing, social distancing, and face masking should be imposed on general public to contain viral dissemination from both symptomatic and asymptomatic patients with this highly contagious disease.
format article
author Yinjie Gao
Xuemei Ma
Jingfeng Bi
Jindong Chu
Bo Liu
Chunsheng Chi
Jianguo Yan
Xiaoli Yu
Fangming Liu
Xiaohong Deng
Hongbing Zhang
Bo Jin
author_facet Yinjie Gao
Xuemei Ma
Jingfeng Bi
Jindong Chu
Bo Liu
Chunsheng Chi
Jianguo Yan
Xiaoli Yu
Fangming Liu
Xiaohong Deng
Hongbing Zhang
Bo Jin
author_sort Yinjie Gao
title Epidemiological and clinical differences of coronavirus disease 2019 patients with distinct viral exposure history
title_short Epidemiological and clinical differences of coronavirus disease 2019 patients with distinct viral exposure history
title_full Epidemiological and clinical differences of coronavirus disease 2019 patients with distinct viral exposure history
title_fullStr Epidemiological and clinical differences of coronavirus disease 2019 patients with distinct viral exposure history
title_full_unstemmed Epidemiological and clinical differences of coronavirus disease 2019 patients with distinct viral exposure history
title_sort epidemiological and clinical differences of coronavirus disease 2019 patients with distinct viral exposure history
publisher Taylor & Francis Group
publishDate 2020
url https://doaj.org/article/0dea6c10186f428eb2dce132e7933820
work_keys_str_mv AT yinjiegao epidemiologicalandclinicaldifferencesofcoronavirusdisease2019patientswithdistinctviralexposurehistory
AT xuemeima epidemiologicalandclinicaldifferencesofcoronavirusdisease2019patientswithdistinctviralexposurehistory
AT jingfengbi epidemiologicalandclinicaldifferencesofcoronavirusdisease2019patientswithdistinctviralexposurehistory
AT jindongchu epidemiologicalandclinicaldifferencesofcoronavirusdisease2019patientswithdistinctviralexposurehistory
AT boliu epidemiologicalandclinicaldifferencesofcoronavirusdisease2019patientswithdistinctviralexposurehistory
AT chunshengchi epidemiologicalandclinicaldifferencesofcoronavirusdisease2019patientswithdistinctviralexposurehistory
AT jianguoyan epidemiologicalandclinicaldifferencesofcoronavirusdisease2019patientswithdistinctviralexposurehistory
AT xiaoliyu epidemiologicalandclinicaldifferencesofcoronavirusdisease2019patientswithdistinctviralexposurehistory
AT fangmingliu epidemiologicalandclinicaldifferencesofcoronavirusdisease2019patientswithdistinctviralexposurehistory
AT xiaohongdeng epidemiologicalandclinicaldifferencesofcoronavirusdisease2019patientswithdistinctviralexposurehistory
AT hongbingzhang epidemiologicalandclinicaldifferencesofcoronavirusdisease2019patientswithdistinctviralexposurehistory
AT bojin epidemiologicalandclinicaldifferencesofcoronavirusdisease2019patientswithdistinctviralexposurehistory
_version_ 1718425462566289408